Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 9, 2026

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.4K

Machine Learning-Based Immune Subgroup Classification of Solid Tumors Using RNA-Seq Data.

Jordan Poots, Gholamreza Rafiee

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |December 3, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparative effects of viable and gamma-irradiated Bifidobacterium longum subsp. infantis on immune modulation and resistance to furunculosis in rainbow trout (Oncorhynchus mykiss).

    BMC microbiology·2026
    Same author

    Enriched microbial communities for ammonium and nitrite removal from recirculating aquaculture systems.

    Chemosphere·2022
    Same author

    Abatement of water nutrient load in a fish culture system using the aquatic trophic levels.

    Water environment research : a research publication of the Water Environment Federation·2021
    Same author

    Toxicity of polystyrene microplastics on juvenile Oncorhynchus mykiss (rainbow trout) after individual and combined exposure with chlorpyrifos‎.

    Journal of hazardous materials·2020
    Same author

    Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.

    The Lancet. Child & adolescent health·2020
    Same author

    Efficient Noisy Sound-Event Mixture Classification Using Adaptive-Sparse Complex-Valued Matrix Factorization and OvsO SVM.

    Sensors (Basel, Switzerland)·2020

    A new machine learning model accurately classifies tumor immune microenvironment (TIME) subgroups, aiding immunotherapy prediction. It identifies a novel seventh subgroup, enhancing understanding of tumor heterogeneity and personalized treatment strategies.

    Area of Science:

    • Oncology
    • Immunology
    • Bioinformatics

    Background:

    • Accurate classification of tumor immune microenvironment (TIME) subgroups is crucial for predicting immunotherapy response and guiding personalized treatment.
    • Existing knowledge of TIME subgroups and their correlation with immunotherapy efficacy and prognosis is incomplete, necessitating further investigation into underlying microenvironmental factors.

    Purpose of the Study:

    • To develop and validate a machine learning model for precise classification of TIME subgroups.
    • To identify novel TIME subgroups and understand their implications for tumor heterogeneity.
    • To create a user-friendly tool for researchers and clinicians to leverage TIME classification in immunotherapy research and treatment planning.

    Main Methods:

    • Utilized FPKM-normalized RNA-Seq data from 440 immune-related genes.

    More Related Videos

    Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
    05:58

    Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

    Published on: August 16, 2024

    3.8K
    DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma
    09:58

    DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma

    Published on: June 6, 2025

    981

    Related Experiment Videos

    Last Updated: Jan 9, 2026

    Predictive Immune Modeling of Solid Tumors
    08:50

    Predictive Immune Modeling of Solid Tumors

    Published on: February 25, 2020

    7.4K
    Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
    05:58

    Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

    Published on: August 16, 2024

    3.8K
    DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma
    09:58

    DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma

    Published on: June 6, 2025

    981
  • Developed a classification model using the eXtreme Gradient Boosting (XGBoost) algorithm.
  • Trained the model on 7,300 samples and validated it on an independent test set of 1,826 samples.
  • Integrated Principal Component Analysis (PCA) and T-distributed Stochastic Neighbor Embedding (t-SNE) for visualization and exploratory analysis.
  • Main Results:

    • The XGBoost model achieved high performance with a macro-balanced accuracy of 0.959 and a macro-balanced F1 score of 0.908 on the independent test set.
    • Identified a seventh, predominant TIME subgroup exhibiting mixed characteristics of the six established subgroups, offering new insights into tumor heterogeneity.
    • Deployed the model as a web interface with integrated visualization tools for practical application.

    Conclusions:

    • The developed machine learning model provides accurate and robust classification of TIME subgroups.
    • The identification of a novel seventh subgroup advances the understanding of tumor heterogeneity and its impact on immunotherapy response.
    • The user-friendly web interface facilitates the application of TIME classification in clinical practice and research, potentially improving immunotherapy outcomes and treatment precision.